Colonization and infection with fluoroquinolone-resistantEscherichia coli among cancer patients: Clonal analysis
- 1 November 1998
- journal article
- research article
- Published by Springer Science and Business Media LLC in Infection
- Vol. 26 (6), 379-384
- https://doi.org/10.1007/bf02770840
Abstract
Escherichia coli with high-level fluoroquinolone resistance were isolated from feces and/or various body sites of 16 cancer patients who were on oral fluoroquinolone prophylaxis. Population analysis of fecal isolates in 11 patients showed that fluoroquinoloneresistantE. coli was the only aerobic gram-negative bacillus present and exhibited a relatively homogenous fluoroquinolone MIC distribution. Molecular typing by pulsed field gel electrophoresis of chromosomal DNA digests or by random amplified polymorphic DNA fingerprinting confirmed the clonal nature of gastrointestinal tract colonization withE. coli. Genotyping of ten colonies picked from the same fecal culture demonstrated identical strains in four of four patients examined. Identical genotypes from the same patient were isolated over prolonged periods of time in 12 of 12 cases examined, with one patient (with the longest follow-up of 14 months) who lost his initial genotype and became persistently colonized with a new genotype. In the 11 patients who developed infection due to fluoroquinolone-resistantE. coli, molecular typing also indicated that fecal colonization was associated with, and presumably preceded infection due to an indistinguishable genotype of fluoroquinolone-resistantE. coli.Keywords
This publication has 19 references indexed in Scilit:
- Fluoroquinolone Resistance in Neisseria gonorrhoeaeEmerging Infectious Diseases, 1997
- Vancomycin-resistant Enterococcus faecium on a pediatric oncology ward: duration of stool shedding and incidence of clinical infectionThe Pediatric Infectious Disease Journal, 1996
- Prophylaxis with Fluoroquinolones for Bacterial Infections in Neutropenic Patients: A Meta-AnalysisClinical Infectious Diseases, 1996
- Editorial Response: Is Resistant Escherichia coli Bacteremia an Inevitable Outcome for Neutropenic Patients Receiving a Fluoroquinolone as Prophylaxis?Clinical Infectious Diseases, 1995
- Mechanisms of Resistance to FluoroquinolonesDrugs, 1995
- Characterization of fluoroquinolone-resistant mutants of escherichia coli selected in vitroAntimicrobial Agents and Chemotherapy, 1994
- Escherichia coli Resistant to Fluoroquinolones in Patients with Cancer and NeutropeniaNew England Journal of Medicine, 1994
- Emergence of fluoroquinolone-resistant Escherichia coli at a cancer centerAntimicrobial Agents and Chemotherapy, 1994
- Phenotypic characterization of quinolone-resistant mutants of Enterobacteriaceae selected from wild type, gyrA type and multiplyresistant (marA) type strainsJournal of Antimicrobial Chemotherapy, 1991
- Selective antimicrobial modulation of the intestinal tract by norfloxacin in human volunteers and in gnotobiotic mice associated with a human fecal floraAntimicrobial Agents and Chemotherapy, 1986